NCT01933321View on ClinicalTrials.gov

Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

Intrathecal autologous stem cell

Mobilization and collection of stem cells for intravenous and intrathecal administration

Trial Locations (1)

64460

Servicio Hematología Hospital Universitario, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT01933321 - Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter